Eli Lilly's John LechLeiter - CEO Pay

John Lechleiter - Eli Lilly

Total Compensation: $13M

Details: With Lechleiter's move up to the top spot at Eli Lilly, the company's executive compensation committee increased his annual salary by 21 percent to $1.4 million, effective April 2008. He received $6.62 million in stock and $2.2 million in non-equity incentive plan compensation. Finally, Lechleiter garnered  $87,107 in "other" compensation, including $80,348 for savings plan match and the rest for tax reimbursements for expenses for his spouse to "attend certain company functions involving spouse participation."

Lilly News:
Lilly CEO 'hungry' for new buyouts
Lilly chief: Megamergers 'driven by weakness'
Lilly execs pull down $48M 
Lilly CEO: It's my job to take risks 

Eli Lilly's John LechLeiter - CEO Pay

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.